Global Myopia Treatment Devices Market Poised for Strong Growth at a CAGR of ~8% by 2032, Driven by Technological Innovations and Increasing Eye Care Demand | DelveInsight
The myopia treatment devices market is primarily driven by the increasing prevalence of myopia and high myopia, advancements in vision correction technologies, rising awareness of early intervention and preventive care, and the growing product development efforts of leading market players.
New York, USA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Global Myopia Treatment Devices Market Poised for Strong Growth at a CAGR of ~8% by 2032, Driven by Technological Innovations and Increasing Eye Care Demand | DelveInsight
The myopia treatment devices market is primarily driven by the increasing prevalence of myopia and high myopia, advancements in vision correction technologies, rising awareness of early intervention and preventive care, and the growing product development efforts of leading market players.
DelveInsight’s Myopia Treatment Devices Market Insights report provides the current and forecast market analysis, individual leading myopia treatment devices companies’ market shares, challenges, myopia treatment devices market drivers, barriers, trends, and key myopia treatment devices companies in the market.
Myopia Treatment Devices Market Summary
- The global myopia treatment devices market size is expected to increase from ~USD 12 billion in 2024 to ~USD 18 billion by 2032, reflecting strong and sustained growth.
- The global myopia treatment devices market is expected to grow at a CAGR of ~8% during the forecast period from 2025 to 2032.
- The leading companies working in the myopia treatment devices market include CooperVision (CooperCompanies), Johnson & Johnson Services Inc., Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes, SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., Esahorus srl, Falco lenses AG, and others.
- Among all the regions, North America is anticipated to register the fastest growth in the myopia treatment devices market during the forecast period.
- In the product type segment of the myopia treatment devices market, the glasses category accounted for the largest market share in 2024.
To read more about the latest highlights related to the myopia treatment devices market, get a snapshot of the key highlights entailed in the Global Myopia Treatment Devices Market Forecast Report
Key Factors Contributing to the Rise in Growth of the Myopia Treatment Devices Market
Rising Prevalence of Myopia
The global increase in myopia, particularly among children and young adults, is a major driver. Lifestyle changes, such as prolonged screen time, reduced outdoor activities, and increased near-work tasks, have contributed to higher rates of refractive errors, creating a greater demand for corrective and treatment devices.
Technological Advancements in Devices
Innovations in optical, pharmacological, and surgical devices, such as orthokeratology lenses, atropine eye drops, and advanced contact lenses, have improved the safety, efficacy, and convenience of myopia management. These technological improvements encourage adoption among both patients and eye care professionals.
Increasing Awareness of Eye Health
Public awareness campaigns and educational programs emphasizing the importance of early detection and management of myopia are boosting patient adoption of treatment devices. Parents and caregivers are increasingly seeking preventive measures to slow the progression of myopia in children.
Growing Healthcare Infrastructure
Regions with robust healthcare systems, availability of eye care specialists, and accessibility to advanced ophthalmic equipment support the expansion of the myopia treatment devices market. This infrastructure facilitates better diagnosis, prescription, and monitoring of treatment devices.
Favorable Reimbursement Policies
Insurance coverage and reimbursement schemes for eye care devices in certain countries reduce the out-of-pocket burden on patients, making myopia treatment devices more affordable and increasing market penetration.
Urbanization and Lifestyle Changes
Urban populations often experience higher levels of myopia due to increased near-vision activities and reduced outdoor exposure. The growing urban demographic, particularly in Asia and North America, directly correlates with rising demand for corrective and preventive devices.
Get a sneak peek at the myopia treatment devices market dynamics @ Myopia Treatment Devices Market Trends
Regional Myopia Treatment Devices Market Insights
In 2024, North America held the largest portion of the myopia treatment devices market, accounting for 34%. The high prevalence of refractive errors, robust healthcare infrastructure, and ongoing technological innovations drive this growth. Additionally, strong public awareness of eye health and favorable reimbursement policies further support the adoption of advanced treatment solutions in the region.
Europe also plays a significant role in the expansion of the myopia treatment devices market. The region benefits from a well-developed healthcare system, widespread awareness of eye care, and rapid adoption of cutting-edge technologies. A comprehensive network of ophthalmic clinics offers a broad spectrum of treatments, ranging from conventional eyeglasses and contact lenses to laser-based procedures and innovative myopia control products.
The Asia-Pacific region is rapidly emerging as a significant growth market for myopia treatment devices, driven by the increasing incidence of myopia, particularly among children and young adults in countries such as China, Japan, South Korea, and India. Contributing factors include prolonged screen exposure, intense educational pressures, and limited outdoor activities, resulting in a large population in need of both corrective and preventive interventions.
To know more about why North America is leading the market growth in the myopia treatment devices market, get a snapshot of the Myopia Treatment Devices Market Share
Recent Developmental Activities in the Myopia Treatment Devices Market
- In August 2025, CooperVision gained approval from Japan’s Ministry of Health, Labor, and Welfare for the manufacture and sale of its MiSight 1-day contact lenses, making it the first soft lens in the country authorized for use by children to correct myopia and control its progression.
- In June 2025, France became the first country in the EU to offer reimbursement for HOYA MiYOSMART spectacle lenses for myopia management. Children aged 5 to 16 with high and/or rapidly progressive myopia are now eligible to receive MiYOSMART lenses on a reimbursement basis.
- In March 2025, Bausch + Lomb Corporation announced the U.S. launch of Arise, a lens-fitting system utilizing cloud-based technology to streamline orthokeratology lens design. Arise synced with topographers to create precise lens designs in seconds and included the first FDA-approved ortho-K lenses with toric peripheral curves to treat myopia overnight.
- In January 2025, ZEISS Medical Technology announced that the MEL 90 had received FDA approval, granting excimer laser technology simultaneous approval for all three major indications: myopia, hyperopia, and mixed astigmatism.
What are Myopia Treatment Devices?
Myopia treatment devices have emerged as practical solutions to slow the progression of nearsightedness and reduce dependence on corrective eyewear. One of the most widely adopted options is orthokeratology (Ortho-K) lenses, which are specially designed rigid contact lenses worn overnight to temporarily reshape the cornea, allowing for clear vision during the day without the need for glasses or lenses. Additionally, specialized soft contact lenses, such as dual-focus or multifocal designs, have been developed to control myopia progression in children by reducing peripheral hyperopic defocus. These devices not only improve visual clarity but also target the underlying mechanisms that drive the elongation of the eyeball, which is a key factor in the progression of myopia.
| Myopia Treatment Devices Market Report Metrics | Details |
| Coverage | Global |
| Study Period | 2022–2032 |
| Myopia Treatment Devices Market CAGR | ~8% |
| Myopia Treatment Devices Market Size by 2032 | ~USD 18 Billion |
| Key Myopia Treatment Devices Companies | CooperVision (CooperCompanies), Johnson & Johnson Services Inc., Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes, SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., Esahorus srl, Falco lenses AG, and others |
Myopia Treatment Devices Market Assessment
-
Myopia Treatment Devices Market Segmentation
- Myopia Treatment Devices Market Segmentation By Product Type: Corrective Lens {Contact Lenses [Soft Contact Lenses, Rigid Gas Permeable Contact Lenses, Ortho-K Lenses, and Others]}, Glasses (Spectacles), and Phakic Intraocular Lenses), Laser Based Refractive Surgery Devices [Excimer Laser System and Femtosecond Laser Systems]
- Myopia Treatment Devices Market Segmentation By End-User: Hospitals, Specialty Clinics, and Others
- Myopia Treatment Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the myopia treatment devices market are set to emerge as the trendsetter explore @ Myopia Treatment Devices Market Analysis
Table of Contents
| 1 | Myopia Treatment Devices Market Report Introduction |
| 2 | Myopia Treatment Devices Market Executive Summary |
| 3 | Competitive Landscape |
| 4 | Regulatory Analysis |
| 5 | Myopia Treatment Devices Market Key Factors Analysis |
| 6 | Myopia Treatment Devices Market Porter’s Five Forces Analysis |
| 7 | Myopia Treatment Devices Market Layout |
| 8 | Myopia Treatment Devices Market Company and Product Profiles |
| 9 | KOL Views |
| 10 | Project Approach |
| 11 | About DelveInsight |
| 12 | Disclaimer & Contact Us |
Interested in knowing the myopia treatment devices market by 2032? Click to get a snapshot of the Myopia Treatment Devices Market Assessment
Related Reports
Myopia Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key myopia companies, including Cloudbreak Pharma, Sunhawk Vision Biotech, Inc., iVeena Delivery Systems, Inc., Stuart Therapeutics, among others.
Myopia Clinical Trial Analysis
Myopia Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key myopia companies, including Cloudbreak Pharma, Sunhawk Vision Biotech, Inc., iVeena Delivery Systems, Inc., Stuart Therapeutics, among others.
Adult Myopia Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key adult myopia companies, including Genentech, Bayer AG, among others.
Contact Lenses Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key contact lenses companies, including Alcon Inc., Cooper Vision Inc., Johnson & Johnson Vision, Bausch Health Companies Inc., HOYA Vision Care Company, Contamac, ZEISS Group, SynergEyes, Menicon Co., Ltd., Gelflex, Orion Vision Group, Solotica, medios, SEED CO. LTD, among others.
DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us Shruti Thakur info@delveinsight.com +14699457679
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
